Literature DB >> 27723072

Components of metabolic syndrome in the first trimester of pregnancy as predictors of adverse perinatal outcome.

Michał Migda1, Marian S Migda, Bartosz Migda, Patrycja Krzyżanowska, Ewa Wender-Ożegowska.   

Abstract

OBJECTIVES: It is the prospective observational study aimed at early prediction of pregnancy complications in women with symptoms of MS.
MATERIAL AND METHODS: 124 Caucasian women in singleton pregnancies 11th to the 13th wks 6 days of gestation with MS criteria compared to 30 healthy controls. Perinatal maternal and fetal results were analyzed.
RESULTS: Increased in the MS group were: age (32.9 y vs. 28.6 y; p = 0,00), weight 11 to 13 + 6 weeks of gestation (79.0 kg vs. 59.7 kg; p = 0.00), BMI (29 kg/m² vs. 21.6 kg/m²; p = 0.00), waist-hip ratio (WHR) (0.9 vs. 0.8; p = 0.00). Maternal serum parameters were higher in the MS group: LDL-cholesterol (124.1 vs. 109.6 mg/dL; p = 0.02), t-PA (2556.8 vs. 1949.5 pg/mL; p < 0.00), GGTP (16.8 vs. 13.3 IU/L; p = 0.02) and lower values for: adiponectin (6.4 vs. 7.5 μg/mL; p = 0.01), SHBG (273.4 vs. 338.4 nmol/L; p = 0.001). MS group neonates higher body weight (3594.4 vs. 3312.2 g; p = 0.01), significantly frequent macrosomic neo-nates (> 4000 g) (20.9% vs. 6.6%; p = 0.042), GDM (12% vs. 0; p = 0.019).
CONCLUSIONS: Higher E-selectin serum concentration, GGTP and lower SHBG in first trimester are additionally to fasting maternal glucose, higher BMI and maternal age predictive for GDM. Higher E-selectin, fasting glucose, increased BMI and lower adiponectin serum concentration in first trimester are significant predictors of fetal macrosomia. Maternal BMI > 24.5 kg/m² is the best predictor of increased risk of fetal macrosomia and gestational diabetes mellitus.

Entities:  

Keywords:  E-selectin; adiponectin; body mass index (BMI); gestational diabetes mellitus; macrosomy; metabolic syndrome

Mesh:

Substances:

Year:  2016        PMID: 27723072     DOI: 10.5603/GP.2016.0060

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  6 in total

1.  Glycosylated fibronectin as a first trimester marker for gestational diabetes.

Authors:  Julia Alanen; Heidi Appelblom; Teemu Korpimaki; Heikki Kouru; Mikko Sairanen; Mika Gissler; Markku Ryynanen; Jaana Nevalainen
Journal:  Arch Gynecol Obstet       Date:  2020-07-11       Impact factor: 2.344

2.  Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Endocrine       Date:  2020-09-15       Impact factor: 3.633

3.  Comparison of global definitions of metabolic syndrome in early pregnancy among the Rajarata Pregnancy Cohort participants in Sri Lanka.

Authors:  Imasha Upulini Jayasinghe; Thilini Chanchala Agampodi; Ajith Kumara Dissanayake; Shalka Madushan Srimantha; Suneth Buddhika Agampodi
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

Review 4.  Association between maternal adiposity measures and adverse maternal outcomes of pregnancy: Systematic review and meta-analysis.

Authors:  Nicola Heslehurst; Lem Ngongalah; Theophile Bigirumurame; Giang Nguyen; Adefisayo Odeniyi; Angela Flynn; Vikki Smith; Lisa Crowe; Becky Skidmore; Laura Gaudet; Alexandre Simon; Louise Hayes
Journal:  Obes Rev       Date:  2022-04-25       Impact factor: 10.867

Review 5.  Association between maternal adiposity measures and infant health outcomes: A systematic review and meta-analysis.

Authors:  Giang Nguyen; Louise Hayes; Lem Ngongalah; Theophile Bigirumurame; Laura Gaudet; Adefisayo Odeniyi; Angela Flynn; Lisa Crowe; Becky Skidmore; Alexandre Simon; Vikki Smith; Nicola Heslehurst
Journal:  Obes Rev       Date:  2022-07-08       Impact factor: 10.867

6.  Maternal metabolic factors and the association with gestational diabetes: A systematic review and meta-analysis.

Authors:  Nahal Habibi; Aya Mousa; Chau Thien Tay; Mahnaz Bahri Khomami; Rhiannon K Patten; Prabha H Andraweera; Molla Wassie; Jared Vandersluys; Ali Aflatounian; Tina Bianco-Miotto; Shao J Zhou; Jessica A Grieger
Journal:  Diabetes Metab Res Rev       Date:  2022-04-25       Impact factor: 8.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.